BIOLIFE SOLUTIONS INC (BLFS) Stock Cash Flow
NASDAQ:BLFS - Nasdaq - US09062W2044 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -46.02M | -66.43M | -139.81M | -8.91M | 1.98M | |||
| Depreciation Amortization | 9.33M | 12.29M | 16.48M | 12.86M | 5.07M | |||
| Income Taxes - Deferred | -190.00K | -62.00K | -5.24M | -20.13M | -3.30M | |||
| Change In Working Capital | 4.34M | 1.47M | -14.91M | -2.26M | -1.10M | |||
| Interest Paid | 1.77M | 1.93M | 590.00K | 450.00K | N/A | |||
| Other non cash items | 41.63M | 40.23M | 134.99M | 13.84M | 3.99M | |||
| OPERATING CASH FLOW | 9.10M | -12.50M | -8.49M | -4.59M | 6.65M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.92M | -11.24M | -13.92M | -14.76M | -7.81M | |||
| Other Investing Activity | 8.54M | 29.07M | -44.20M | 1.56M | -16.91M | |||
| INVESTING CASH FLOW | -11.38M | 17.84M | -58.12M | -13.19M | -24.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.00M | -498.00K | 17.84M | -2.89M | 980.00K | |||
| Stock Issued/Repurchased | 10.52M | 10.75M | 320.00K | 1.42M | 101.59M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | -374.00K | 338.00K | -1.84M | -1.30M | -500.00K | |||
| FINANCING CASH FLOW | 7.14M | 10.59M | 16.32M | -2.78M | 102.08M | |||
| Exchange Rate Effect | 36.00K | 35.00K | -110.00K | -20.00K | 0.00 | |||
| CHANGE IN CASH | 4.90M | 15.96M | -50.40M | -20.58M | 84.01M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 9.10M | -12.50M | -8.49M | -4.59M | 6.65M | |||
| Capital Expenditure | -19.92M | -11.24M | -13.92M | -14.76M | -7.81M | |||
| FREE CASH FLOW | -10.82M | -23.73M | -22.41M | -19.35M | -1.16M | |||
All data in USD